Axon Unveils Body 5 as Its Stock Sits 26% Lower in 2026. Here's Where ...
π· Axon unveiled the Body 5 body camera on October 24, featuring 25x the AI processing power of earlier models and new features like license scanning.
π° Total revenue grew 35% in Q2, driven by a massive 700% year-over-year surge in AI Era software revenue.
π Shares closed at $420.37 on October 23, down nearly 26% from the previous year's close ahead of the new product launch.
β³ The Body 5 has no announced price or ship date, with availability pending further market analysis.
π Hardware lifecycle averages 2.5 years, but the Body 4 units have been in the field for over three years, potentially delaying upgrades.
π§ Axon's strategy prioritizes becoming the primary AI provider for agencies to drive long-term software adoption over immediate hardware pricing.
β οΈ Rising memory costs are currently exerting downward pressure on the margins of Axon's camera hardware segment.
π Analysts forecast earnings per share growth of roughly 21% annually through 2030, supporting a mid-case target price of ~$1,330.
π Q3 revenue is expected to reach near $938 million (approx. 32% growth) when reported after the close on November 5.
βοΈ The main investment risk involves AI adoption outpacing AI revenue generation, potentially leaving earnings short of model projections.
- Axon's AI Era software segment demonstrated explosive growth with nearly 700% year-over-year revenue increase in the second quarter.
- Total company revenue grew 35% in Q2, significantly outperforming the 29.1% growth rate of the Connected Devices hardware segment.
- The Body 5 camera introduces advanced AI capabilities including license scanning and multi-tool execution, strengthening its software ecosystem.
- Wall Street analysts project a mid-case target price of approximately $1,330 by December 2030, implying significant long-term upside.
- Axon's strategic focus on becoming the primary AI provider for law enforcement agencies supports durable recurring revenue streams.
- Rising memory costs are currently impacting the gross margins of Axon's camera hardware business.
- The Body 4 units have exceeded their average 2.5-year lifecycle, potentially slowing the upgrade cycle for the large installed base.
- Analysts warn that if AI adoption grows faster than AI revenue generation, earnings could fall short of projected growth paths.